Chromatin enrichment of TRIM24, estrogen receptor and H3K4me2 in estrogen-treated and -untreated MCF7 cells
Source: NCBI BioProject (ID PRJNA130083)
Source: NCBI BioProject (ID PRJNA130083)
0 0
Project name: Homo sapiens
Description: TRIM24 PHD-Bromo domains exhibit preferential binding to unmethylated H3K4 and acetylated H3K27. TRIM24 is a co-activator of estrogen receptor (ER). The results suggest that specific ER-binding sites are depleted of H3K4me2 with estrogen treatment. TRIM24 binds these sites preferentially and facilitates ER-regulated gene expression, cell survival and proliferation.Overall design: ChIP performed on MCF7 cells +/- estrogen with antibodies against ER, TRIM24 and H3K4me2. ChIP assays of ER, co-activator TRIM24 and H3K4me2 were performed with two concentrations of antibody, without and 6h with estrogen treatment of MCF7 cells. Antibody-enriched samples were sequenced two times, and compared to an IgG negative control and Input. Enriched DNA sequenced by Illumina Solexa.
Data type: Epigenomics
Sample scope: Multiisolate
Relevance: Medical
Organization: Cincinnati Children's Hospital Medical Center
Literatures
- PMID: 21164480
Release date: 2010-09-17
Last updated: 2010-09-16